Factor X Deficiency: Clinical Trials

4 trials for Factor X Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 withdrawn. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Terminated 1, Withdrawn 1

Follow Factor X Deficiency: new trials by email Literature Review of Factor X Deficiency trials Research Report on Factor X Deficiency

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
Coagadex(R) - Acquired Factor X Deficiency
Phase 3WithdrawnKedrion S.p.A.2026-06-012026-11-05
A Study to Investigate Bio Product Laboratory Ltd (BPL's) Factor X in the Prophylaxis of Bleeding in Children <12 Years
FACTOR X - Factor X Deficiency
Phase 3CompletedBio Products Laboratory92015-04-012018-04-02
Safety & Efficacy of BPL's High Purity FACTOR X in Treatment of Factor X Deficient Subjects Undergoing Surgery
FACTOR X - Factor X Deficiency
Phase 3TerminatedBio Products Laboratory42011-03-012019-02-05
A Study Investigating Treatment Factor X in People With Factor X Deficiency
Human Coagulation FACTOR X - Factor X Deficiency
Phase 3CompletedBio Products Laboratory162010-01-012014-12-12

Narrower conditions

Blood Coagulation Disorders (1)  ·  Hematologic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)

Broader conditions

Blood Coagulation Disorders, Inherited (4)  ·  Coagulation Protein Disorders (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Blood Coagulation Disorders (3)  ·  Hematologic Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Amyloidosis (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphoproliferative Disorders (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Factor X (3)

Sponsors

Bio Products Laboratory (3)  ·  Kedrion S.p.A. (1)

Countries

United Kingdom (3)  ·  Spain (2)  ·  Turkey (Türkiye) (2)  ·  United States (2)  ·  Germany (1)

Top investigators

Amy Shapiro, Dr (1)  ·  Mirella Calcinai, MD (1)  ·  Ri Liesner, Dr (1)  ·  Tim Aldwinckle (1)

Results publications

PMID 29545231